Posted On: Thursday, November 14th, 2013
New and Noteworthy FDA advisory committee recommends the approval of simeprevir and sofosbuvir The Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) unanimously recommended the approval of two direct-acting antivirals for hepatitis C, simeprevir and sofosbuvir. The newer direct-acting antiviral medications are more effective, easier to take and have significantly fewer… Read more »
Posted On: Thursday, November 7th, 2013
Click to read the document!
Posted On: Wednesday, November 6th, 2013
Continue reading
Posted On: Wednesday, November 6th, 2013
The Pacific Hepatitis C Network will be holding its Annual General Meeting on December 9, 2013 in Vancouver from 6 -8 pm. We will be announcing the location soon. This is a great opportunity to get together with other members of the Pacific Hepatitis C Network to share ideas, gain knowledge, and give input…. Read more »
Posted On: Thursday, October 10th, 2013
This is an exciting time in the evolution of HCV treatment in Canada. New approved treatment in the near future will offer patients the opportunity to achieve the highest SVR and cure. The hope is that the new drug Sofosbuvir will meet many current unmet needs and provide patients with the confidence to seek treatment… Read more »
Posted On: Wednesday, September 25th, 2013
HepCBC’s Cheryl Reitz recently attended and presented at the CATIE Fall Educational Conference in Toronto. Cheryl shared the entire presentation with the HepCBC network where she addresses the need for HCV testing in Baby Boomers. Read her speech, HERE
Posted On: Thursday, September 12th, 2013
Germs such as hepatitis B virus (HBV) and hepatitis C virus (HCV) infect and injure the liver. Long-term or chronic infection with either of these viruses can cause inflammation and healthy liver tissue is replaced with useless scar tissue. Prolonged increased levels of liver enzymes in the blood occur, suggestive of ongoing liver injury. Gradually… Read more »
Posted On: Wednesday, September 4th, 2013
Articles included: Liver Transplant Patients from Outside Vancouver face added hurdles URGENT request for Patient Input on SIMEPREVIR by Sept. 11th NEW Online HCV Support Community on “Health Unlocked” Portal NEW CIHR HIV-HCV Coinfection Mgmt & Treatment Guidelines World Hepatitis Day in BC, part II and WHD throughout Canada CATIE article on new HCV Drugs:… Read more »
Posted On: Wednesday, August 14th, 2013
New and Noteworthy Decrease in Hep C infections associated with needle and syringe programs There was a significant reduction in hepatitis C incidence among injection drug users who attended needle and syringe programs in Australia, according to a study in the American Journal of Public Health. As part of a long-term evaluation of the programs,… Read more »
Posted On: Wednesday, August 7th, 2013
To read the entire bulletin, CLICK HERE Continue reading, CLICK HERE
Posted On: Wednesday, July 31st, 2013
Treatment Update: Hepatitis viruses The latest issue of Treatment Update (TU197) covers new research on the use of treatment as prevention as a strategy for decreasing the spread of Hep C, an overview of liver cancer in Canada, as well as risk factors, screening and treatment options for liver cancer. TreatmentUpdate is CATIE’s flagship digest… Read more »
Posted On: Wednesday, July 24th, 2013
HepCBC has been busy compiling a list of World Hepatitis Day events around the Province. Check out the one closest to you! Abbotsford: Your Health… Be Invested… Get Tested When: July 26, 2013 @ 11:00 am – 3:00 pm Where: McCallum Ave. and 5 Corners Jubilee Park, Abbotsford For more information, CLICK HERE … Read more »
